Where does LES Laboratoires Servier rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), LES Laboratoires Servier ranks #4,476 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does LES Laboratoires Servier hold?

LES Laboratoires Servier holds 79 US utility patents granted between 2015 and 2025, spanning 15 technology areas.

What is LES Laboratoires Servier's Innovation Score?

LES Laboratoires Servier has an Innovation Score of 42.8 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does LES Laboratoires Servier focus on?

LES Laboratoires Servier's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 71 patents, ranking #238 of 6,058 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

Is LES Laboratoires Servier's patent grant rate increasing or decreasing?

LES Laboratoires Servier's recent grant velocity is -43% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for LES Laboratoires Servier's patents?

LES Laboratoires Servier's patents average 18.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the LES Laboratoires Servier patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

LES Laboratoires Servier

USPTO PatentsView assignee record - 79 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, LES ranks #4,476 of 49,997 tracked US assignees by granted-patent volume, with 79 patents across 15 technology areas.

#4,476
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.8/100): 18.1
avg claims per patent: -43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4476 · Foreign Corporation #4,476 · 79 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 79 grants
TOP-DECILE #4,476/49,997
PHOTO-FINISH Industry-academic…
CPC-FOCUS A61P · 15 areas
INNOV-PAR 42.8/100
CLAIMS-RICH 18.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -43% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Industry-academic Cooperation Foundation Gyeongsang National University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How LES’s 42.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.1 pts (35%) Velocity 3.1 pts (7%) Breadth 13.7 pts (32%) Claim depth 10.9 pts (25%)

Qualcomm Incorporated · highest

85
Robe lighting s r o · near

43
Accion Systems · near

43
Koch Agronomic… · near

43
LES Laboratoires… · this assignee

43
Reliant Immune… · near

43
3D Lighting… · lowest

7

What this shows LES's Innovation Score is 42.8/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for LES?

Each dot is one of LES’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). LES’s own 18.1 claims/patent is ABOVE the 11.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

LES vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where LES's grants concentrate

LES Laboratoires Servier is a focused PatentsView assignee: 15 CPC subclasses with 89.9% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (16 grants) versus a trough of 4 in 2021. By volume, LES sits between Industry-academic Cooperation Foundation Gyeongsang National University and Nippon Mektron, Ltd..

LES's three-year grant acceleration

From 2019–2021 to 2022–2024, LES Laboratoires Servier moved from 30 to 14 grants (0.47x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Industry-academic…

79
InstituciÓ Catala…

79
Institut Polytech…

79
Ixys

79
NHN Entertainment

79
Nikola

79
Ninebot (Beijing)…

79
Nippon Mektron

79
LES Laboratoires… ◀

79

What this shows LES holds 79 patents at rank #4,476, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near LES

By rank, the assignees closest to #4,476 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in LES's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for LES, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), LES ranks #238 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Reliant Immune Diagnostics, Inc. 43 Koch Agronomic Services, LLC 43 Accion Systems, Inc. 43 Robe lighting s.r.o. 43

Similar claim depth

Nearest assignees by average claims per patent (18.1 here).

Arevo, Inc. 18.1 avg Siemens Product Lifecycle Management Software Inc. 18.1 avg Kansas State University Research Foundation 18.1 avg Crane Payment Innovations, Inc. 18.1 avg

LES's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

LES Laboratoires Servier patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	11.4%
2016	5	6.3%
2017	13	16.5%
2018	6	7.6%
2019	16	20.3%
2020	10	12.7%
2021	4	5.1%
2022	4	5.1%
2023	4	5.1%
2024	6	7.6%
2025partial year	2	2.5%

Which technologies does LES Laboratoires Servier patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 71

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 59

C07D - Heterocyclic Compounds 47

C07K - Peptides 17

C07C - Acyclic OR Carbocyclic Compounds 12

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 12

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 10

C12Y - Enzymes 6

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 5

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

LES Laboratoires Servier's patent record in context - here's where to go next.

LES Laboratoires Servier's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 89.9% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #4,476 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare LES Laboratoires Servier against Industry-academic Cooperation Foundation Gyeongsang National University, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.